Top Analyst Upgrades and Downgrades: Alcoa, Cigna, Intel, Molina, Teva, UnitedHealth and More

Print Email

Stocks were looking to take a breather on Friday morning, but investors are still actively looking for ideas for a bull market or a stock picker’s markets. 24/7 Wall St. reviews dozens of analyst research reports each morning of the week, hunting for new research ideas for our readers. Some analyst calls are about stocks to buy, and some cover stocks to sell or to avoid.

These are this Friday’s top analyst upgrades, downgrades and initiations from Wall Street firms.

Actavis PLC (NYSE: ACT) was started as Buy with a $275 price target at Canaccord Genuity.

Alcoa Inc. (NYSE: AA) was reiterated as Buy at Sterne Agee, but the firm raised its target to $18 from $15 (versus a $14.94 close) after the firm’s transformative acquisition of Firth Rixson.

American Eagle Outfitters Inc. (NYSE: AEO) was raised to Outperform from Market Perform and given a $17 price target (versus a $11.49 close) at FBR Capital Markets.

Analog Devices Inc. (NASDAQ: ADI) was started as Buy at Sterne Agee.

ALSO READ: 11 Analyst Stocks Under $10 With Huge Implied Upside

Centene Corp. (NYSE: CNC) was started as Buy and given a $87 price target (versus a $74.27 close) at Sterne Agee.